// App-Quantinova.ai

POS1449 (2021) : SEGMENTED SHORT-FORMAT ONLINE EDUCATION SIGNIFICANTLY INCREASES PREDICTION, PROGNOSIS, AND MANAGEMENT OF FIBROSING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE

Researchers

Presenter

  • C. Rohani-Montez

Principal Investigators

  • M. Calle

  • C. Allen

  • T. Maher

  • V. Smith

  • J. Jacob

  • G. Riemekasten

  • M. Kolb

Medical Centers

  • Medscape Education Global, Medscape Education Global, London, United Kingdom

  • Keck Medicine of USC, Clinical Medicine, Los Angeles, United States of America

  • Ghent University Hospital, Department of Gastroenterology, Ghent, Belgium

  • University College London, UCL Respiratory, CMIC UCL, London, United Kingdom

  • University Medical Center Schleswig-Holstein, Department of Rheumatology and Clinical Immunology, Lubuck, Germany

  • McMaster University, Division of Neonatology, Department of Pediatrics, Hamilton, Canada

Locations

  • United Kingdom

  • United States

  • Belgium

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • AstraZeneca and GlaxoSmithKline (GSK) and Research and Development (R&D)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved